Small-Cap
Telomir Pharmaceuticals Reports Breakthrough in Oral Therapy for Vision Loss
Telomir-1 reverses retinal degeneration and restores vision in advanced AMD zebrafish model Telomir Pharmaceuticals (TELO) announced a major preclinical breakthrough...
Telomir Pharmaceuticals Secures $3M Premium Equity Investment to Advance Rare Disease Program
Insider-Led Funding with No Warrants Strengthens Balance Sheet Ahead of IND Submission for Telomir-1 Telomir Pharmaceuticals (TELO), a biotech innovator...
Institutional Interest In Telomir Pharmaceuticals
Telomir Pharmaceuticals (TELO) has caught the attention of institutional investors, with JPMorgan Chase & Co. (JPM) significantly increasing its position...
KindlyMD and Nakamoto Merge to Launch Largest Bitcoin Treasury Initiative in Public Markets
$710 Million Raised as David Bailey Leads Ambitious Plan to Transform Bitcoin Adoption Through Public Equity In a landmark move...
Mira Pharmaceuticals Approves Acquisition of SKNY, Creating $60M+ Biotech Platform
Board approves merger following independent valuation; SKNY to contribute $5M in cash or assets at closing Mira Pharmaceuticals (MIRA), a...
WeTouch Secures $100M Deal, Signaling Major Expansion in Touchscreen Market
Landmark agreement with multinational electronics giant paves way for global growth and innovation WeTouch Technology (WETH), a global provider of...
Ideal Power Accelerates Market Entry with Early Completion of First B-TRAN Design Win
Successful Solid-State Circuit Breaker Prototypes Signal Growth Potential Ideal Power (IPWR) has reached a key milestone in its commercialization strategy,...
KULR Technology Reports Strong Revenue Growth and Improved Financial Position
Fourth-Quarter Results Show Increased Cash Reserves and Higher Margins KULR Technology Group (KULR), a leader in advanced energy management platforms,...
Alpha Cognition Launches ZUNVEYL, First Oral Alzheimer’s Drug Approved by FDA in a Decade
32-Person Sales Team Targets $2 Billion Long-Term Care Market as Company Marks Major Milestone in Alzheimer’s Treatment Alpha Cognition (ACOG)...
FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity
BioXcel Therapeutics (BTAI) announced that the U.S. Food and Drug Administration (FDA) has officially closed its inspection of a single...
